|
| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 37 | 2020 | Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic: Perspective from a European country | MOLENBERGHS, Geert; BUYSE, Marc; ABRAMS, Steven; HENS, Niel; Beutels, Philippe; FAES, Christel; VERBEKE, Geert; Van Damme, Pierre; Goossens, Herman; NEYENS, Thomas; HERZOG, Sereina; Theeten, Heidi; Pepermans, Koen; Abad, Ariel Alonso; VAN KEILEGOM, Ingrid; Speybroeck, Niko; LEGRAND, Catherine; De Buyser, Stefanie; Hulstaert, Frank | Journal Contribution | A1 |
| 38 | 2020 | Unbiasedness and efficiency of non-parametric and UMVUE estimators of the probabilistic index and related statistics | VERBEECK, Johan; DELTUVAITE-THOMAS, Vaiva; BERCKMOES, Ben; BURZYKOWSKI, Tomasz; AERTS, Marc; THAS, Olivier; BUYSE, Marc; MOLENBERGHS, Geert | Journal Contribution | A1 |
| 39 | 2019 | Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis | Saad, Everardo D.; Squifflet, Pierre; BURZYKOWSKI, Tomasz; Quinaux, Emmanuel; Delaloge, Suzette; Mavroudis, Dimitris; Perez, Edith; Piccart-Gebhart, Martine; Schneider, Bryan P.; Slamon, Dennis; Wolmark, Norman; BUYSE, Marc | Journal Contribution | A1 |
| 40 | 2019 | Detection of atypical data in multicenter clinical trials using unsupervised statistical monitoring | Trotta, Laura; Kabeya, Yuusuke; BUYSE, Marc; Doffagne, Erik; Venet, David; Desmet, Lieven; BURZYKOWSKI, Tomasz; Tsuburaya, Akira; Yoshida, Kazuhiro; Miyashita, Yumi; Morita, Satoshi; Sakamoto, Junichi; Praveen, Paurush; Oba, Koji | Journal Contribution | A1 |
| 41 | 2019 | A Poisson approach to the validation of failure time surrogate endpoints in individual patient data meta-analyses | Rotolo, Federico; PAOLETTI, Xavier; BURZYKOWSKI, Tomasz; BUYSE, Marc; Michiels, Stefan | Journal Contribution | A1 |
| 6 | 2019 | Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer | BURZYKOWSKI, Tomasz; Coart, E.; Saad, E.D.; Shi, Q.; Sommeijer, D.W.; Bokemeyer, C.; Díaz-Rubio, E.; Douillard, Jean-Yves; Falcone, A.; Fuchs, C.; Goldberg, R.M.; Hecht, R.; Hoff, P.M.; Hurwitz, H.; Kabbinavar, F.F.; Koopman, M.; Maughan, T.; Punt, C.J.A.; Saltz, L.; Schmoll, Hans-Joachim; Seymour, M.T.; Tebbutt, N.C.; Tournigand, C.; Van Cutsem, E.; de Gramont, A.; Zalcberg, J.R.; BUYSE, Marc | Journal Contribution | A1 |
| 7 | 2019 | Chronological Trends in Progression-Free, Overall, and Post-Progression Survival in First-Line Therapy for Advanced NSCLC | Rutkowski, Jacek; Saad, Everardo D.; BURZYKOWSKI, Tomasz; BUYSE, Marc; Jassem, Jacek | Journal Contribution | A1 |
| 8 | 2019 | Assessing Long-Term Survival Benefits of Immune Checkpoint Inhibitors Using the Net Survival Benefit | Peron, Julien; Lambert, Alexandre; Munier, Stephane; Ozenne, Brice; Giai, Joris; Roy, Pascal; Dalle, Stephane; Machingura, Abigirl; Maucort-Boulch, Delphine; BUYSE, Marc | Journal Contribution | A1 |
| 9 | 2018 | The search for surrogate endpoints for immunotherapy trials | BUYSE, Marc; BURZYKOWSKI, Tomasz; Saad, Everardo D. | Journal Contribution | A2 |
| 10 | 2018 | Understanding and Communicating Measures of Treatment Effect on Survival: Can We Do Better? | Saad, Everardo D.; Zalcberg, John R.; Peron, Julien; Coart, Elisabeth; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 11 | 2018 | An extension of generalized pairwise comparisons for prioritized outcomes in the presence of censoring | Peron, Julien; BUYSE, Marc; Ozenne, Brice; Roche, Laurent; Roy, Pascal | Journal Contribution | A1 |
| 12 | 2018 | Statistical evaluation of surrogate endpoints in cancer clinical trials | BUYSE, Marc; MOLENBERGHS, Geert; PAOLETTI, Xavier; Oba, K.; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, Tomasz | Book Section | B2 |
| 13 | 2017 | Applied Surrogate Endpoint Evaluation Methods with SAS and R | ALONSO ABAD, Ariel; BIGIRUMURAME, Theophile; BURZYKOWSKI, Tomasz; BUYSE, Marc; MOLENBERGHS, Geert; MUCHENE, Leacky; PERUALILA, Nolen Joy; SHKEDY, Ziv; VAN DER ELST, Wim | Book | B1 |
| 14 | 2017 | Exploratory analysis of the association of depth of response and survival in patients with metastatic non-small-cell lung cancer treated with a targeted therapy or immunotherapy | Saad, Everardo D.; BUYSE, Marc | Journal Contribution | A2 |
| 15 | 2017 | Evaluation of failure time surrogate endpoints in individual patient data meta-analyses of randomized clinical trials. A poisson approach | Rotolo, Federico; PAOLETTI, Xavier; BURZYKOWSKI, Tomasz; BUYSE, Marc; Michiels, Stefan | Journal Contribution | M |
| 16 | 2017 | Adoption of Pathologic Complete Response as a Surrogate End Point in Neoadjuvant Trials in HER2-Positive Breast Cancer Still an Open Question | BURZYKOWSKI, Tomasz; Saad, Everardo D.; BUYSE, Marc | Journal Contribution | A1 |
| 17 | 2017 | Precision medicine needs randomized clinical trials | Saad, Everardo D.; PAOLETTI, Xavier; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 18 | 2017 | Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid Tumors | Michiels, Stefan; Saad, Everardo D.; BUYSE, Marc | Journal Contribution | A1 |
| 19 | 2017 | The impact of data errors on the outcome of randomized clinical trials | BUYSE, Marc; Squifflet, Pierre; Coart, Elisabeth; Quinaux, Emmanuel; Punt, Cornelis J. A.; Saad, Everardo D. | Journal Contribution | A1 |
| 20 | 2017 | The potential and perils of observational studies | BUYSE, Marc; Vansteelandt, Stijn | Journal Contribution | A1 |
| 21 | 2017 | Use of the Beta-Binomial Model for Central Statistical Monitoring of Multicenter Clinical Trials | Desmet, Lieven; Venet, David; Doffagne, Erik; Timmermans, Catherine; LEGRAND, Catherine; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 22 | 2017 | Authors' Reply to Schoenfeld: "Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid Tumors" | Michiels, Stefan; Saad, Everardo D.; BUYSE, Marc | Journal Contribution | A1 |
| 23 | 2017 | Improving public health by improving clinical trial guidelines and their application | Landray, Martin J.; Bax, Jeroen J.; Alliot, Laurence; BUYSE, Marc; Cohen, Adam; Collins, Rory; Hindricks, Gerhard; James, Stefan K.; Lane, Sile; Maggioni, Aldo P.; Meeker-O'Connell, Ann; Olsson, Gunnar; Pocock, Stuart J.; Rawlins, Michael; Sellors, Jonathan; Shinagawa, Kaori; Sipido, Karin R.; Smeeth, Liam; Stephens, Richard; Stewart, Murray W.; Stough, Wendy Gattis; Sweeney, Fergus; Van de Werf, Frans; Woods, Kerrie; Casadei, Barbara | Journal Contribution | A1 |
| 24 | 2016 | Data Sharing - Is the Juice Worth the Squeeze? | Strom, Brian L.; BUYSE, Marc; Hughes, John; Knoppers, Bartha M. | Journal Contribution | A1 |
| 25 | 2016 | Fraud in clinical trials: complex problem, simple solutions? | Sakamoto, Junichi; BUYSE, Marc | Journal Contribution | A2 |
| 26 | 2016 | Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer | Michiels, Stefan; Pugliano, L.; Marguet, S.; Grun, D.; Barinoff, J.; Cameron, D.; Cobleigh, M.; Di Leo, A.; Johnston, S.; Gasparini, G.; Kaufman, B.; Marty, M.; Nekljudova, V.; Paluch-Shimon, S.; Penault-Llorca, F.; Slamon, D.; Vogel, C.; von Minckwitz, G.; BUYSE, Marc; Piccart, M. | Journal Contribution | A1 |
| 27 | 2016 | Statistical monitoring of data quality and consistency in the Stomach Cancer Adjuvant Multi-institutional Trial Group Trial | Timmermans, Catherine; Doffagne, Erik; Venet, David; Desmet, Lieven; LEGRAND, Catherine; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 28 | 2016 | Statistical evaluation of surrogate endpoints with examples from cancer clinical trials | BUYSE, Marc; MOLENBERGHS, Geert; PAOLETTI, Xavier; Oba, Koji; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 29 | 2016 | Neoadjuvant as Future for Drug Development in Breast Cancer-Letter | BUYSE, Marc; BURZYKOWSKI, Tomasz; Saad, Everardo D. | Journal Contribution | A1 |
| 30 | 2016 | The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical Trials | Peron, Julien; Roy, Pascal; Ozenne, Brice; Roche, Laurent; BUYSE, Marc | Journal Contribution | A1 |
| 31 | 2016 | Response to the letter to the editor 'Reply to "Statistical controversies in clinical research: end points other than survival are vital for regulatory approval of anticancer agents" by H. K. van Halteren' | Saad, E. D.; BUYSE, Marc | Journal Contribution | A1 |
| 32 | 2016 | Adaptive Randomization of Neratinib in Early Breast Cancer | BUYSE, Marc; Saad, E.; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 33 | 2016 | An Information-Theoretic Approach for the Evaluation of Surrogate Endpoints Based on Causal Inference | ALONSO ABAD, Ariel; VAN DER ELST, Wim; MOLENBERGHS, Geert; BUYSE, Marc; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 34 | 2016 | Statistical controversies in clinical research: end points other than overall survival are vital for regulatory approval of anticancer agents | Saad, E. D.; BUYSE, Marc | Journal Contribution | A1 |
| 35 | 2016 | Neratinib after trastuzumab in patients with HER2-positive breast cancer Reply | Chan, Arlene; BUYSE, Marc; Yao, Bin | Journal Contribution | A1 |
| 36 | 2015 | Event-Free Survival Is a Surrogate for Overall Survival in Patients Treated for Acute Myeloid Leukemia | Schlenk, Richard F.; Doehner, Hartmut; Doehner, Konstanze; Ganser, Arnold; Heuser, Michael; Benner, Axel; BUYSE, Marc; BURZYKOWSKI, Tomasz | Journal Contribution | M |
Loading...
5
0
5
0
false